DOCSLIB.ORG

Cochrane Database of Systematic Reviews (CDSR)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cochrane Database of Systematic Reviews (CDSR) Web Appendix 2 BTS Bronchiectasis Guideline literature searches Sources to be searched; Cochrane Database of Systematic Reviews (CDSR) Database of Abstracts of Reviews of Effects (DARE) Health Technology Assessment Database (HTA) Cochrane Central Register of Controlled Trials (CENTRAL) MEDLINE and MEDLINE In-Process EMBASE Date range searched: all years All study types English language studies only Cochrane Library (includes CDSR, DARE, HTA and CENTRAL) http://www.thecochranelibrary.com Searched online 26/11/13 Strategy saved as: bts bronchiectasis #1 MeSH descriptor: [Bronchiectasis] explode all trees (160) #2 bronchiecta*:ti,ab,kw (Word variations have been searched) (421) #3 #1 OR #2 (424) Of 424 total results in entire Cochrane Library 26 were from Cochrane Database of Systematic Reviews (CDSR), 6 from Database of Reviews of Effects (DARE), 2 from Health Technology Assessment Database (HTA) and 388 from Cochrane Central Register of Controlled Trials (CENTRAL). All results saved to Endnote library marked ‘CDSR/DARE/HTA/CENTRAL 04/06/14 in Custom 4 field as appropriate. MEDLINE and MEDLINE In-Process Searched 04/06/14 via OVID interface Strategy saved as: BTS bronchiectasis final medline Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1946 to Present> 1 *bronchiectasis/ or bronchiectasis.ti. (4592) 2 limit 1 to english language (2645) 2645 total results saved to Endnote library marked ‘MEDLINE & MEDLINE In-Process 04/06/14 in Custom 4. EMBASE Searched 04/06/14 via OVID interface Strategy saved as: BTS bronchiectasis final embase EMBASE 1974 to 2014 June 3 1 *bronchiectasis/ or bronchiecta$.ti. (5726) 2 limit 1 to (english language and embase) (2198) 2198 total results saved to Endnote library marked ‘EMBASE 06/04/14 in Custom 4. Total Results Database Results After deduplication Custom 4 field Cochrane Database 26 26 CDSR 06/04/14 of Systematic Reviews Database of 6 6 DARE 06/04/14 Abstracts of Reviews of Effects Health Technology 2 2 HTA 06/04/14 Assessment Database MEDLINE and 2645 2566 MEDLINE 06/04/14 MEDLINE In- Process EMBASE 2198 1021 EMBASE 06/04/14 Cochrane Central 388 227 CENTRAL 06/04/14 Register of Controlled Trials Total 5265 3848 All results saved to compressed Endnote library ‘BTS bronchiectasis guideline 2014.enlx’ BTS Bronchiectasis Guideline 2016 searches Sources to be searched; Cochrane Database of Systematic Reviews (CDSR) Database of Abstracts of Reviews of Effects (DARE) Health Technology Assessment Database (HTA) Cochrane Central Register of Controlled Trials (CENTRAL) MEDLINE and MEDLINE In-Process EMBASE PubMed Date range searched: all years All study types English language studies only To deduplicate results against previous results found from searches carried out in 2014. Cochrane Library (includes CDSR, DARE, HTA and CENTRAL) via Wiley http://www.thecochranelibrary.com Searched on 25/04/2016 CDSR: Issue 4 of 12, April 2016 DARE: Issue 2 of 4, April 2015 HTA: Issue 2 of 4, April 2015 CENTRAL: Issue 3 of 12, March 2016 #1 MeSH descriptor: [Bronchiectasis] explode all trees 184 #2 bronchiecta*:ti,ab,kw 548 #3 #1 or #2 554 Of 554 total results in from Cochrane Library 28 were from Cochrane Database of Systematic Reviews (CDSR), 9 from Database of Reviews of Effects (DARE), 2 from Health Technology Assessment Database (HTA) and 512 from Cochrane Central Register of Controlled Trials (CENTRAL). MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations via Ovid http://ovidsp.ovid.com/ Searched on 25/04/2016 1946-present 1 *Bronchiectasis/ (4815) 2 bronchiecta$.ti. (3525) 3 1 or 2 (5187) 4 limit 3 to english language (3073) 3073 results were retrieved. EMBASE Searched 04/06/14 via OVID interface 1974 – 2016 April 22 1 *bronchiectasis/ (6455) 2 bronchiecta$.ti. (4313) 3 1 or 2 (6765) 4 limit 3 to english language (4011) 4011 results were retrieved. PubMed http://www.ncbi.nlm.nih.gov/pubmed/ Searched on 25/04/2016 (((pubstatusaheadofprint OR publisher[sb] OR pubmednotmedline[sb]))) AND (("Bronchiectasis"[Majr]) OR bronchiecta*[Title]) 238 results were retrieved. Total Results Database Results After Custom 4 field deduplication MEDLINE & MEDLINE in process 3073 433 UPDATE MEDLINE & in process Ovid 25/04/2016 EMBASE 4011 503 UPDATE EMBASE 25/04/2016 Ovid CENTRAL 512 52 UPDATE CENTRAL 25/04/2016 Wiley PubMed 238 23 UPDATE PubMed 25/04/2016 CDSR 28 9 UPDATE CDSR 25/04/2016 Wiley DARE 9 2 UPDATE DARE 25/04/2016 Wiley HTA 2 1 UPDATE HTA 25/04/2016 Wiley total 7873 1023 1023 results saved to compressed EndNote library ‘BTS bronchiectasis update 2016.enlx’ .
Load more

Recommended publications
  • The Effective Health Care Research Consortium (EHCRC) Publication
    Consortium Publication Policy, 20 February 2013 The Effective Health Care Research Consortium (EHCRC) Publication policy The Effective Health Care Research Consortium (the Consortium) has extensive experience in medical publishing, research ethics, and principles of research integrity. Using this experience, and helped by a specialist in the field, we have drawn up this policy document to help promote capacity development in research integrity. 1 This policy applies to all supported Consortium activities. In addition, we encourage partners to use this to prompt their own departments and institutions to develop similar explicit policies. 1. Scope This policy relates to academic publications in peer-reviewed journals including systematic reviews published on The Cochrane Library. This includes authors working with the Cochrane Infectious Diseases Group (CIDG), all Consortium supported Cochrane authors, and all Consortium supported research publications. The policy applies to all outputs from the programme and associated grants (for example, self-published material, reports, newsletters, and blogs). 2. General principles Work supported by the Consortium will be published in a timely and responsible manner. All reports and publications will endeavour to present findings in a responsible, objective and accurate manner and without undue delays. Those who have made a significant contribution to the research will be recognised appropriately by authorship or acknowledgement. 3. Registration of systematic reviews and clinical trials All systematic reviews initiated by the consortium that are not registered as Cochrane Reviews will be prospectively registered on a suitable register (such as PROSPERO). We expect anyone receiving Consortium funds as support to their work (as money, or in kind, such as payment of travel) will, should they be involved in a clinical trial, ensure this trial is registered prospectively (i.e.
    [Show full text]
  • Cochrane Collaboration Conversation with Givewell
    Meeting between Cochrane Collaboration representatives and GiveWell at the U.S. Cochrane Center, May 8, 2012. From the Cochrane Collaboration: Kay Dickersin Director of the U.S. Cochrane Center and the Eyes and Vision Review Group, U.S. Satellite Lorne Becker Director of the Cochrane Collaboration Trading Company and Cochrane Innovations Jeremy Grimshaw Co-Chair, Cochrane Steering Group, Director of the Canadian Cochrane Center, and Coordinating Editor of the Cochrane Effective Practice and Organization of Care Roger Soll Coordinating Editor of the Neonatal Review Group and Member of the Executive Board of the Review Group Coordinating Editors Lisa Bero Director, U.S. Cochrane Center (San Francisco Branch) and Cochrane World Health Organization delegate George Rutherford Coordinating Editor, HIV/AIDS Review Group From GiveWell: Holden Karnofsky and Stephanie Wykstra These notes reflect answers that Cochrane representatives gave during our conversation. Cochrane Collaboration’s aims: • Cochrane Collaboration’s primary aim is to produce high quality systematic reviews of existing health-related research. The organization also trains researchers to do systematic reviews, develops better methods for analyzing and comparing studies in its systematic reviews and educates researchers in the use of these methods, and advocates for evidence-based decision- making within the World Health Organization (WHO), governments, professional associations, consumers and other groups. Structure of the organization: • The Cochrane Collaboration uses a multilevel level organizational and governance structure, comprising a group of “entities” that are organized around functions related to conducting and disseminating systematic reviews of the evidence. Each Cochrane organization (or “entity”) provides its own governance structure and is responsible for raising its own funding.
    [Show full text]
  • Evaluation of NIHR Investment in Cochrane Report
    Evaluation of NIHR investment in Cochrane infrastructure and systematic reviews Committee members: Professor Jos Kleijnen (Chair), Dr Phil Alderson, Dr Jane Aubin, Professor John Cairns, Ms Sally Crowe, and Professor Paul Garner Report writer: Kate Misso 10 February 2017 1 TABLE OF CONTENTS LIST OF TABLES ............................................................................................................................ 5 LIST OF FIGURES ........................................................................................................................... 6 LIST OF ABBREVIATIONS ............................................................................................................... 7 EXECUTIVE SUMMARY ............................................................................................................... 10 1. The global landscape of systematic reviews ............................................................................. 10 2. The performance of NIHR funded Cochrane Review Groups (CRGs) ....................................... 11 3. Cochrane’s impact on key clinical and policy issues in the NHS ............................................... 13 4. The economic impact of systematic reviews ............................................................................ 14 5. Current and planned developments in Cochrane and stakeholders’ views ............................. 14 Conclusions ......................................................................................................................................
    [Show full text]
  • How to Develop a Search Strategy for an Intervention Review
    How to develop a search strategy for an intervention review Based on the Peer Review of Electronic Search Strategies (PRESS) criteria* PRESS Guide Examples 1 Translation If possible, structure the search strategy into 1. Index term(s) for Patient/Population/Problem Is the search question search concepts (groups of words) according to 2. Text word(s) for Patient/Population/Problem translated well into search relevant elements from PICOS: 3. 1 OR 2 (P) concepts? 4. Index term(s) for Intervention(s) Patient/Population/Problem 5. Text word(s) for Intervention(s) Intervention Comparator 6. 4 OR 5 (I) Outcome 7. Publication type(s) Study design (methods filter) 8. Index term(s) for Study design(s) 9. Text word(s) for Study design(s) 10. 7 OR 8 OR 9 (S) 11. 3 AND 6 AND 10 (P AND I AND S) You might want to omit the Comparator and the Outcome elements as they are not often described adequately in the title, abstract or indexing. 2 Operators See the database’s help file to find available Are there any mistakes in operators used to combine individual terms and the use of Boolean or search concepts proximity operators? AND, OR , NOT, NEXT, NEAR/n, adj/n are common operators AND between terms or concepts narrows the search OR between terms or concepts broaden the 1 2019 03 13 search Use the NOT operator with caution – you might A search for: ‘NOT-out’ terms you want to keep private health NOT public health will exclude papers that are about private health and also about public health 3 Subject headings/index Subject headings or index terms (like MeSH used Vaccination terms in MEDLINE for example) are terms that describe Guidelines as Topic Are any important subject the content of an article – what it is about Randomized Controlled Trials as Topic headings missing or have Publication type terms describe what kind of Guideline any irrelevant ones been publication the article is Randomized Controlled Trial included? Check all relevant index terms for each of the databases you will search Some index terms cover the P and also the I in 1.
    [Show full text]
  • Searching the Cochrane Library Training Guide[Pdf]
    Searching the Cochrane Library To book your place on the course contact the library team: www.epsom-sthelier.nhs.uk/lis E: [email protected] T: 020 8296 2430 Learning objectives At the end of this session you should be able to: Identify when to use Cochrane Log on to the Cochrane Library databases from home and work Formulate a search string, using basic Boolean logic Search using Keywords and MeSH terms Use the search history function to combine search results Refine search criteria by author or title View records from each database and navigate through a review Print records from each database View graphs and tables from a review What is the Cochrane Library? The Cochrane Library is a database of reliable evidence on the effectiveness of healthcare interventions. It is regarded as the best resource available of this type. The Cochrane Library is put together by the Cochrane Collaboration, the NHS Centre for Reviews and Dissemination and other related organisations and is updated quarterly. When should you use the Cochrane Library? The Cochrane Library should be used when looking for the best evidence on the effectiveness of treatment and health promotion interventions. The best type of evidence comes from systematic reviews and randomised controlled trials (RCTs). It is also a source of information on the methodology of systematic reviews. It should be used when looking for information on the effectiveness of an intervention, for example: What is the effectiveness of treatment y? What is the effectiveness of treatment
    [Show full text]
  • Efficacy of Low-Level Laser Therapy for Tinnitus
    brain sciences Article Efficacy of Low-Level Laser Therapy for Tinnitus: A Systematic Review with Meta-Analysis and Trial Sequential Analysis Chih-Hao Chen 1, Chii-Yuan Huang 1,2, Chun-Yu Chang 3 and Yen-Fu Cheng 1,2,4,5,* 1 Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei 112, Taiwan; [email protected] (C.-H.C.); [email protected] (C.-Y.H.) 2 Faculty of Medicine, National Yang-Ming University, Taipei 112, Taiwan 3 Department of Anesthesiology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan; [email protected] 4 Department of Medical Research, Taipei Veterans General Hospital, Taipei 112, Taiwan 5 Institute of Brain Science, National Yang-Ming University, Taipei 112, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2871-2121 (ext. 1292) Received: 13 November 2020; Accepted: 30 November 2020; Published: 2 December 2020 Abstract: Study Objective: Tinnitus is a common disorder characterized by sound in the ear in the absence of external or internal stimuli. Low-level laser therapy (LLLT) was discovered enhancing tissue repair via increasing the blood microcirculation and cell proliferation in 1960s. In the last two decades, LLLT delivered to the cochlea has frequently been used to reduce the severity of tinnitus. However, whether LLLT effectively attenuates the severity of tinnitus remains controversial. We aimed to evaluate the efficacy of low-level laser therapy on adult patients with complaints of tinnitus. Design: Systematic review and meta-analysis with trial sequential analysis. Interventions: Low-level laser therapy (LLLT). Measurements: Tinnitus Handicap Inventory (THI) score; improvement rates of the visual analog scale (VAS), verbal rating scale (VRS) and numeric rating scale (NRS) scores.
    [Show full text]
  • Scientific Literature Resources: a Guide for CNRA Employees
    Scientific Literature Resources: A Guide for CNRA Employees GAVIN NEWSOM, GOVERNOR FEBRUARY 2020 PREPARED BY Nicole Waugh, California Energy Commission Library Amy Loseth, California Geological Survey Library Jenny Woo, California Energy Commission Library CDFW Literature Access SIFT (Science Institute Focus Group) 2 TABLE OF CONTENTS INTRODUCTION ............................................................................................................................... 7 SECTION 1: ONLINE RESOURCES ..................................................................................................... 8 1.1 Citation Databases ................................................................................................................ 8 Scopus ...................................................................................................................................... 8 Google Scholar ......................................................................................................................... 8 Pubmed .................................................................................................................................... 8 1.2 Databases .............................................................................................................................. 9 Biodiversity Heritage Library ................................................................................................... 9 Birds of North America ...........................................................................................................
    [Show full text]
  • Protocol Template (Protocol)
    Protocol template (Protocol) NN This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2013, Issue 9 http://www.thecochranelibrary.com For Preview Only Protocol template (Protocol) Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 BACKGROUND .................................... 1 OBJECTIVES ..................................... 1 METHODS ...................................... 1 Figure1. ..................................... 3 REFERENCES ..................................... 5 ADDITIONALTABLES. 6 APPENDICES ..................................... 7 CONTRIBUTIONSOFAUTHORS . 21 DECLARATIONSOFINTEREST . 21 For Preview Only Protocol template (Protocol) i Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Protocol] Protocol template NN1 1Not specified Contact address: N N, Not specified. Editorial group: Cochrane Metabolic and Endocrine Disorders Group. Publication status and date: New, published in Issue 9, 2013. Citation: N N. Protocol template. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CDXXXXXX. DOI: 10.1002/14651858.CDXXXXXX. Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ABSTRACT This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of ... How the intervention
    [Show full text]
  • Low-Level and High-Power Laser Therapy
    MEDICAL POLICY Low-Level and High-Power Laser Therapy Effective Date: 7/1/2020 Section: MED Policy No: 272 Technology Assessment Committee Approved Date: 4/10; 7/12; 8/13; 7/14; 7/15; 4/16: 7/1/2020 Medical Policy Committee Approved Date: 1/03; 2/04; 1/0; 1/07; 3/08; 5/17; 10/17; 12/18; 2/19; 5/19; Medical Officer Date 6/2020 See Policy CPT/HCPCS CODE section below for any prior authorization requirements SCOPE: Providence Health Plan, Providence Health Assurance, Providence Plan Partners, and Ayin Health Solutions as applicable (referred to individually as “Company” and collectively as “Companies”). APPLIES TO: All lines of business BENEFIT APPLICATION Medicaid Members Oregon: Services requested for Oregon Health Plan (OHP) members follow the OHP Prioritized List and Oregon Administrative Rules (OARs) as the primary resource for coverage determinations. Medical policy criteria below may be applied when there are no criteria available in the OARs and the OHP Prioritized List. POLICY CRITERIA I. Low-level laser therapy (i.e., cold laser therapy) and high-power laser therapy (i.e., class IV laser) is considered investigational and is not covered for the treatment of any indication including, but not limited to, the following (A- G.): A. Carpal tunnel syndrome B. Hair loss C. Low back pain D. Rotator cuff tendinopathy E. Pressure ulcers F. Oral mucositis G. Chronic pain Link to Policy Summary Page 1 of 17 MED272 MEDICAL POLICY Low-Level and High-Power Laser Therapy CPT/HCPCS CODES All Lines of Business Not Covered 0552T Low-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professional S8948 Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes Unlisted Codes All unlisted codes will be reviewed for medical necessity, correct coding, and pricing at the claim level.
    [Show full text]
  • A Guide to Electronic Health Care/Medical Libraries on the Internet
    American International Health Alliance A Guide to Electronic Health Care/Medical Libraries on the Internet Compiled by: Irina Ibraghimova, Library and Information Management Specialist, HealthConnect International [email protected] The guide is produced by the American International Health Alliance as part of its Learning Resources project. This guide provides information on how to obtain access to a variety of full-text health and medical journals, books, and other resources. The following on-line resources are included: International and National Projects HINARI. Access to Research in Health Programme Programme for the Enhancement of Research Information (PERii) Access to Research for Development and Innovation (ARDI) Journal Articles and Books Collections African Index Medicus BIOLINE – International BioMed Central BLDS Digital Library Directory of Open Access Journals Directory of Open Access Books (DOAB) Free Medical Books Free Medical Journals Geneva Foundation for Medical Education and Research - Free Medical Journals HighWire Press Free Online Full-text Articles HighWire Press Free Access to Developing Economies LSHTM Research Online Medicalstudent.com - Medical Textbooks Medknow Medscape National Academies Press PLoS POPLINE PubMed Bookshelf PubMed Central PubMed Free Link Out Journals SciELO Public Health ScienceDirect WHO Medicines Bookshelf EBM resources Cochrane Library BMJ Clinical Evidence WHO Reproductive Health Library American International Health Alliance Full-text Internet Resources Search Tools FreeFullPDF OAIster Open
    [Show full text]
  • Evidence-Based Medicine (EBM): What Long-Term Care Providers Need to Know
    Evidence-Based Medicine (EBM): What Long-Term Care Providers Need to Know Huai Y. Cheng, MD, MPH KEYWORDS Evidence-based medicine Long-term care facility Nursing homes EBM Evidence-based medicine (EBM) has been exponentially disseminated to every field of medicine over past 2 decades.1–7 EBM is now a part of postgraduate competency through practice-based learning.8 However, its potential use in the long-term care setting was only recently appreciated in the literature.1,9,10 EBM may play an important role in reforming nursing homes and improving quality care.1–5,9,10 The simple search term “EBM,” limited to English and human in Medline, generated 49,304 citations, which narrowed to only 173 when “nursing homes” was added, indi- cating that EBP is not rare and is being implemented in long-term care. It has been a great effort that each article in this special issue presents evidence-based recommen- dations to long-term care providers to guide their daily practice. In contrast to the evidence-based approach to individual geriatric conditions addressed in the other arti- cles in this issue, this article briefly introduces the basic concept of EBM; addresses some potential benefits, harms, and challenges of its practice in a long-term care setting; and promotes its appropriate use among providers of long-term care. For those who already know the EBM basics and are interested in become experts, several textbooks on EBM are recommended.11–13 Attending an EBM workshop, such as one run by McMaster University,14 could also be helpful.
    [Show full text]
  • The Cochrane Collaboration: a Valuable Knowledge Translation Resource
    TECHNICAL BRIEF NO. 29 2010 A Publication of the National Center for the Dissemination of Disability Research (NCDDR) Focus The Cochrane Collaboration: A Valuable Knowledge Translation Resource The Cochrane Collaboration has become the premier source worldwide of high-quality systematic reviews in health care. Cochrane’s importance has even been compared to that of the Human Genome Project (Naylor, 1995). The Cochrane Collaboration’s focus on health care applies in many ways to disability and rehabilitation, particularly in the health and function domain. The purpose of this FOCUS Technical Brief is to provide a brief overview of The Cochrane Collaboration and to highlight entities and resources of the Collaboration that can assist disability and rehabilitation researchers and knowledge users in their knowledge translation (KT) efforts. Cochrane Background and Philosophy The Cochrane Collaboration exists for the purpose of Professor making accurate and up-to-date information about Archibald Leman Cochrane CBE FRCP FFCM health-care effects readily available worldwide and (1909–1988) encompasses some 28,000 contributors in more Source: Cardiff University than 100 countries. The Collaboration is named after Library, Cochrane Archive, Professor Archie Cochrane, an epidemiologist who University Hospital Llandough. Retrieved from stressed the importance of properly evaluating health- The Cochrane Collaboration (www.cochrane.org/about- care interventions—particularly through randomized us/history/archie-cochrane) controlled trials —to ensure that limited health-care [Permission not needed.] resources used interventions that were proved to be effective. The Collaboration was formally launched collaboration, avoiding duplication of effort, and in October 1993, and is a registered not-for-profit enabling consumer participation (see Figure 1).
    [Show full text]